Prism Medico and Pharmacy Ltd.
BSE: PRISMMEDI · Non Banking Financial Company (NBFC) · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 250 companies in Non Banking Financial Company (NBFC) (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Operating profit covered interest -78.9x in the last 12 months.
- Net loss in 5 of the last 7 quarters.
- No dividend in the last 5 financial years.
- Price ₹34.99 on 2026-10-26: 0.0% from the 52-week high, +125.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| EBITDA | -0 | 0 | 1 | -0 | -0 | -0 | -0 |
| OPM % | -4.8% | 14.3% | 40.9% | -20.0% | -28.6% | -42.9% | – |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -0 | 0 | 1 | -0 | -0 | -0 | -0 |
| EPS (₹) | 0.00 | 0.07 | 0.01 | 0.00 | 0.02 | 0.30 | 0.04 |
| Revenue YoY | -66.7% | +300.0% | -100.0% | ||||
| Profit YoY | – | -700.0% | -109.1% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 8 | 1 | 3 | 1 | 2 | 1 |
| EBITDA | -0 | -0 | -0 | -0 | 0 | -0 |
| Net profit | -0 | -0 | -0 | -0 | 0 | -0 |
| EPS (₹) | -0.06 | -0.01 | – | 0.08 | 0.53 | 0.36 |
| Revenue growth | -85.0% | +130.7% | -78.5% | +287.3% | – | |
| Profit growth | – | – | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +24.4% | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | +6.6% (2y) | +49.1% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 15 | 15 |
| Borrowings | 0 | 0 |
| Cash & equivalents | 0 | 0 |
| Total assets | 16 | 16 |
| Fixed assets | 0 | 0 |
| Capital work in progress | 0 | 0 |
| Investments | 0 | 0 |
| Receivables | 4 | 4 |
| Inventory | 7 | 7 |
| Payables | 0 | 0 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | -0 | 0 |
| Cash from investing | 0 | 0 |
| Cash from financing | 0 | 0 |
| Capex | 0 | 0 |
| Free cash flow | -0 | 0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | -0.3% | 2.1% |
| ROCE % | -0.4% | 2.8% |
| Debtor days | 2,070 | 588 |
| Inventory days | 5,510 | 1,575 |
| Payable days | 0 | 29 |
| Cash conversion cycle (days) | 7,580 | 2,134 |
| Working capital days | 8,564 | 2,280 |
Peers in Non Banking Financial Company (NBFC)
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| BAJFINANCE | ₹5,71,790 cr | 28.1x | 5.2x | 19.9% | – | – | +25.1% | 0.60% |
| SHRIRAMFIN | ₹1,55,223 cr | 14.6x | 2.4x | 18.5% | – | – | +17.4% | 0.94% |
| TATACAP | ₹1,27,155 cr | 34.6x | 3.3x | 9.3% | – | – | – | 0.14% |
| CHOLAFIN | ₹1,23,499 cr | 21.4x | 4.1x | 21.2% | – | – | +34.4% | 0.14% |
| MUTHOOTFIN | ₹96,184 cr | 9.1x | 2.5x | 32.1% | – | – | +37.9% | 1.08% |
| LTF | ₹60,381 cr | 17.1x | 2.1x | 12.8% | – | – | +273.2% | 1.14% |
| SBICARD | ₹51,225 cr | 22.5x | 3.3x | 15.4% | – | – | +13.3% | 0.42% |
| PIRAMALFIN | ₹44,923 cr | 21.9x | 1.4x | 6.3% | – | – | – | 0.55% |
| SUNDARMFIN | ₹43,352 cr | 22.5x | 3.4x | 16.2% | – | – | +23.8% | 0.95% |
| PRISMMEDI | ₹28 cr | 97.2x | 1.8x | -2.6% | -1.8% | -45.5% | +24.4% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Financial Services |
| Industry | Non Banking Financial Company (NBFC) |
| Sub-industry | Non Banking Financial Company (NBFC) |
| Symbol | PRISMMEDI |
| BSE code | 512217 |
| ISIN | INE730E01016 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.